Shueng Pei-Wei, Lin Shih-Chiang, Chong Ngot-Swan, Lee Hsing-Yi, Tien Hui-Ju, Wu Le-Jung, Chen Chien-An, Lee Jason J S, Hsieh Chen-Hsi
Department of Radiation Oncology, Far Eastern Memorial Hospital, 21, Nan-Ya S. Rd., Sec.2 Pan-Chiao, Taipei 220, Taiwan.
Technol Cancer Res Treat. 2009 Feb;8(1):29-38. doi: 10.1177/153303460900800105.
Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTV(extremities) and with 0.5 cm margin for all other bones of CTV. A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTV (Bone marrow) of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively. The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.
选择3例IgG为主的Ⅲa期浆细胞骨髓瘤亚洲患者进行自体造血细胞移植(HSCT)。以美法仑140mg/m²进行全身骨髓照射(TMI)断层放疗作为HSCT的预处理方案。分别以2.5mm和5mm层厚对计划的上、下部分进行两组计算机断层扫描(CT)图像扫描。确定计划上、下部分的衔接点并标记在双大腿膝关节上方15cm处。临床靶区(CTV)包括整个骨骼系统。计划靶区(PTV)在CTV(四肢)外放0.8cm生成,在CTV的所有其他骨骼外放0.5cm边界。向PTV给予总剂量800cGy(200cGy/分次)。截至报告时,注意到3例移植后患者均无疾病活动迹象。在TMI治疗期间,观察到1例1级呕吐、2例1级恶心、1例1级黏膜炎和3例1级厌食。根据不良事件通用术语标准v3.0(CTCAE v3.0)对治疗毒性进行评分。PTV(骨髓)上、下部分的CI和H指数平均值分别为1.5和1.4,以及1.2和1.2。相对于全身照射(TBI),TMI断层放疗对头部、胸部和腹部各危及器官的剂量降低分别为31%至74%、21%至51%和46%至63%。不同平移方向上躯干上部与下肢的最大平均配准值在治疗前分别为5.1mm和4.1mm,治疗后分别为1.5mm和0.7mm。上部与下部在射束开启时间、摆位时间和MVCT配准时间方面的平均治疗时间分别约为49.9、23.3和11.7分钟以及11.5、10.0和7.3分钟。在良好固定并通过MVCT确认位置接近的情况下,PTV边界可小于1cm。在TMI全过程应预防性使用止吐药。对于亚洲人,TMI技术替代8Gy全身照射作为多发性骨髓瘤预处理方案是可接受的,且结果是可行的。